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AORTIC VALVE 
PRESERVATION IN ACUTE 
TYPE A DISSECTION: 
IS IT SOUND? 
A series of 200 consecutive patients with acute Stanford type A dissection 
(157 men, 78%: 43 women, 22%) was analyzed to assess the validity of aortic 
valve preservation or repair. Indication for the operation in most cases was 
based on echocardiographic examination alone, to reduce the delay. In the 
majority of patients (111/200, 56%) the aortic valve was preserved or 
repaired if necessary. Aortic root replacement with a composite graft was 
performed in 66 of 200 patients (33%), mainly because of an enlarged aortic 
anulus and sinus. Replacement of the aortic valve and the supracoronary 
ascending aorta was performed in 23 of 200 patients (12%) with a diseased 
aortiC valve (e.g., bicuspid valve) but an acceptable aortic sinus. Follow-up 
totaled 656 patient-years (maximum 14 years). Actuarial analyses as a 
function of type of repair and type of aortic valve provided the following 
probabilities plus or minus errors (95%): overall survival of the 200 
patients was 78.3% -+ 2.9% after 30 days, 74.95% _+ 3.1% after 1 year, 
67.9% - 3.6% after 5 years, and 48.5% - 6.1% after 10 years. Actuarial 
probability of freedom from reoperation for valve failure in the complete 
series was calculated as 100.0% _ 0.0% after 30 days, 99.3% -+ 0.7% after 
1 year. 97.5% - 1,5% after 5 years, and 95.1% _+ 2.8% after i0 years. During 
long-term follow-up, there was no significant difference among groups with 
regard to structural deterioration, valve thrombosis, thromboembolic com- 
plications, anticoagulant-induced hemorrhage, and endocarditis. Freedom 
from valve failure and valve-related complications are similar for pre- 
served, repaired, mechanical, and biologic valves. Valve-related reopera- 
tions are rare during at least 5 years of follow-up. Hence preservation or 
repair of the aortic valve can be recommended in the majority of patients 
with acute type A dissection. (J THORAC CARDIOVASC SURG 1996;111:381-91) 
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A cute aortic dissection 1-3 remains a challenging entity in cardiovascular surgery despite the 
progress that has been made regarding its diagnosis 
and treatment. Transesophageal echocardiography, 
which can be done as a bedside procedure, not only 
speeds up the diagnostic process 4' s but also allows 
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for dynamic evaluation of intimal flaps, true and 
false lumina, entries and reentries, flow patterns and 
thrombosed Channels, native vessels including the 
supraaortic arteries and the coronary arteries, and 
the aortic valve. 
Therapeutic options now include sealed grafts, 
sealed composite grafts, biologic glue, 6' 7 glutaralde- 
hyde-preserved xenopericardium, 8 and improved 
perfusion techniques. Recent technical modifica- 
tions in operations for type A aortic dissections 
focused on the distal anastomosis, where repair of 
the aortic arch 9 and the advantages of open distal 
anastomoses have been stressed. However, tiie type 
of proximal repair of the ascending aorta is Of great 
interest oo, because one of the major perioperative 
decisions to be made is whether the aortic valve has 
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Fig. 1. Actuarial survival probabilities of all patients undergoing operations for acute type A aortic 
dissection (_+95% errors). 
Table I. Distribution of  patients as a function of  the aortic valve and the aortic root, respectively 
Type of valve 
All Preserved Mechanical Biologic 
Type of graft No. % No. % No. % No. % 
All 200/200 100 111/200 56 69/200 35 20/200 10 
Supracoronary 134/200 67 111/200 56 18/200 9 5/200 3 
Composite 66/200 33 0/200 0 51/200 26 15/200 8 
to be replaced or whether it can be preserved or 
repaired. The present study was performed to estab- 
lish the long-term outcome of native aortic valves 
preserved or repaired in situ during operations for 
acute type A aortic dissections. 
Patients and methods 
This study includes a series of 200 consecutive patients 
undergoing surgical treatment at Zurich University Hos- 
pital for acute dissection of the ascending aorta, which is 
classified type A in accordance with the guidelines et 
forth by the Stanford group) The dissection was defined 
as acute if chest pain or other symptoms occurred less than 
14 days before the Operation, as suggested by Fann and 
colleagues, a° If symptoms occurred more than 14 days 
before the operation, the dissection was termed subacute. 
Data concerning the procedure were obtained by retro- 
spective review of hospital records, whereas follow-up 
information was collected systematically throughout the 
follow-up period. A final update was achieved by written 
or telephone contacts with the patients, their families, or 
their physicians. Follow-up was complete in 94.3% and 
totaled 655 patient-years. Mean follow-up was 50 months 
(maximum 172 months). However, because of the length 
of the study period, up to 14 years, echocardiographic 
follow-up was not available for the earlier patients. It was 
therefore decided not to rely on this incomplete informa- 
tion for valve evaluation and to present only the valve 
failure data leading to reoperation. 
The series of 200 patients analyzed comprised 154 men 
(77%) and 46 women (23%) with a mean age of 55 _+ 6 
years (range 14 to 78 years). Over time, the diagnostic 
workup has evolved from angiography to computed to- 
mography and finally transesophageal chocardiography. 
To reduce the delay in diagnosis in the patients with acute 
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Fig. 2. Actuarial survival probabilities of patients with supracoronary grafts (squares) versus patients with 
composite grafts (rhombi) (+95% errors). There is no statistically significant difference between groups. 
dissection, we now use transesophageal chocardiography 
as our standard approach. The therapeutic decision is 
generally based on the patient's history and the echocar- 
diographic findings alone. In this study, acute aortic 
dissections were diagnosed in 161 of 200 patients (81%) 
and subacute dissection in 39 of 200 patients (19%). 
Information on aortic valve function before the opera- 
tion was not available in some patients in whom the 
primary diagnosis was made by computed tomography or 
angiography, but it was available in 174 patients (87%). 
Among these 174 patients, some degree of aortic incom- 
petence was diagnosed in 57 of 105 patients (54%) who 
had preservation or repair of native aortic valves (estimate 
of regurgitation 34% _+ 14%), 35 of 50 patients (70%: no 
significant difference vs preservation) who had insertion of 
a composite graft (estimate of regurgitation 49% _+ 16%), 
and 13 of 19 patients (68%: no significant difference vs 
preservation) with aortic valve replacement and supra- 
coronary graft placement (estimate of regurgitation: 
58% -+ 14%). In these subgroups, acute dissections diag- 
nosed less than 72 hours after the first symptom were 
operated on in 67 of 105 patients (64%) with preservation 
or repair of the native aortic valve, with a composite graft 
in 24 of 50 patients (48%: no significant difference vs 
preservation) and with aortic valve replacement and su- 
pracoronary graft placement in 16 of 19 patients (84%: no 
significant difference vs preservation). 
Surgical technique. In this series the ascending aorta 
was replaced with a Dacron polyester graft in all patients. 
The aortic arch was replaced in part or as a whole in 37 of 
the 200 patients (19%). The aortic root, however, was 
handled in three different ways: (1) The aortic valve was 
preserved, the commissures were repositioned if neces- 
sary, and the ascending aortic graft was placed in the 
supracoronary position. This was our preferred approach 
and was applied in 111 of the 200 patients (56%). (2) The 
aortic valve was replaced and the ascending aortic graft 
was sutured in the supracoronary position. This approach 
was selected in 23 of the 200 patients (12%) with a 
diseased aortic valve (e.g. bicuspid valve) but an accept- 
able configuration of the aortic sinus portion. (3) The 
aortic root was replaced with a composite graft (valve plus 
conduit necessitating reimplantation of the coronary ar- 
teries). This procedure was selected in 66 of the 200 
patients (33%), mainly because of an enlarged aortic 
anulus and sinus portion. 
Femoral artery cannulation, median sternotomy ap- 
proach, total cardiopulmonary bypass, and cold, high- 
potassium cardioplegic cardiac arrest were standard. 
More recently, biologic glue, retrograde blood cardiople- 
gia, and hypothermic irculatory arrest for open distal 
anastomosis became routine. Whenever possible, the na- 
tive aortic valve was preserved or repaired in situ. Con- 
struction of a sandwich, the dissected layers of the aortic 
root being sewn with monofilament sutures between strips 
of Teflon felt and the ascending aortic graft, was the 
preferred technique in the earlier part of the study (100% 
at the beginning of the analyzed series). In this group the 
commissures of the aortic valve were repositioned if 
necessary and included in the suture of the proximal 
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Fig. 3. Actuarial probability of freedom from reoperation for all patients (_+95% errors). 
Table II. Distribution of all reoperations as a function of type of valve and type of graft 
Type of valve 
All Preserved Mechanical Biologic 
Type of graft No. % No. % No. % No. % 
All 18/200 9 11/111 10 5/69 7 2/20 10 
Supracoronary 13/134 10 11/111 10 1/18 6 1/5 20 
Composite 5/66 8 0/0 0 4/51 8 1/15 7 
All valve-reIated and non-valve-related surgical procedures during follow-up (reoperations due to structural valve failure are analyzed in actuarial fashion: 
see Figs. 6 and 7). 
anastomosis. More recently, the aortic root was usually 
repaired with biologic glue after polymerization and al- 
lowing for direct suture with or without graft material. 
This is now our preferred approach (100% at the end of 
the analyzed period). Teflon felt can be avoided in most 
cases. Commissural resuspension, consolidation, or reduc- 
tion of the aortic sinus resulting in some type of aortic 
valve repair was performed 67 of the 111 patients (60%) 
in whom the native aortic valve was preserved. 
In the majority of patients with a diseased aortic valve 
or an enlarged aortic root, the aortic valve was replaced 
with a bileaflet mechanical device; in a minority, it was 
replaced with a glutaraldehyde-preserved porcine biologic 
valve that was carefully rinsed three times before implan- 
tation, as recommended by the manufacturer. As a rule, 
life-long anticoagulation with warfarin sodium (Couma- 
din) analogs was maintained inpatients receiving mechan- 
ical aortic valves, whereas low-dose heparin was given 
during the hospital stay to patients with preserved or 
repaired native or biologic aortic valves. 
Statistical analyses. Statistical analysis was performed 
for the population as a whole, as well as in accordance 
with the surgical approach selected--(a) composite graft 
repair versus (b) aortic valve replacement and supracoro- 
nary graft implantation versus (c) aortic valve preserva- 
tion or repair and supracoronary graft implantation. In 
addition, the outcome was analyzed as a function of the 
type of aortic valve at risk. Three groups can be distin- 
guished: patients with a preserved or repaired native 
aortic valve, patients with a mechanical aortic valve, and 
patients with a porcine biologic aortic valve. Survival and 
event-free probabilities plus or minus errors (95%) were 
calculated by actuarial analyses. 1M3 Student's t test was 
used for comparison of parametric data and Fisher's exact 
test for comparison of nonparametric data if applicable. A 
p value less than 0.05 was considered significant. 
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Fig. 4. Actuarial probability of freedom from reoperation for patients with supracoronary grafts (squares) 
versus those with composite grafts (rhombi) (_+95% errors). There is no statistically significant difference 
between groups. 
Resu l ts  
Distribution of patients in accordance with the 
type of valve and the type of aortic graft is shown in 
Table I. The following analyses are concentrated on 
the results of the series as a whole (all 200 patients), 
patients with Supracoronary grafting (134/200: 67%) 
versus patients with a composite graft (66/200: 
33%), and patients with a preserved or repaired 
native aortic valve left in situ (111/200: 56%) versus 
patients with a mechanical aortic valve (69/200: 
35%) versus patients with a biologic aortic valve 
(20/200: 10%). 
Survival. Overall actuarial survival probability of 
the 200 analyzed patients was 78.3% _+ 2.9% after 
30 days, 74.9% _+ 3.1% after 1 year, 67.9% _+ 3.6% 
after 5 years, and 48.5% _+ 6.1% after 10 years (Fig. 
1). For patients who underwent supracoronary 
grafting of the ascending aorta (134/200: 67%) with 
or without replacement of the aortic valve, survival 
was 75.2% _+ 3.8% after 30 days, 71.6% +_ 4.0% 
after 1 year, 65.2% _+ 4.6% after 5 years, and 
42.4% _+ 8.5% after 10 years. The corresponding 
figures for patients who underwent implantation of 
a composite graft (66/200 patients: 33%) were 
85.6% -- 4.2% after 30 days, 80.8% _+ 4.8% after 
1 year, 72.9% + 5.7% after 5 years, and 57.5% _+ 
9.2% after 10 years (no significant difference among 
groups (Fig. 2). For the complete series excluding 
early mortality (158/200 patients: 79%), 1-year sur- 
vival was 96.7% _+ 1.7% versus 86.8% +_ 3.3% after 
5 years and 61.9% _+ 7.5% after 10 years. For early 
survivors of supracoronary grafting (i02/158: 65%), 
1-year survival was 96.6% _+ 1.9% versus 86.7% _+ 
4.3% after 5 years and 56.4% _+ 10.9% after 
10 years. The corresponding figures for early survi- 
vors with a composite graft (56/158: 35%) were 
94.5% _+ 3.1% after 1 year, 85.3% _+ 5.2% after 
5 years, and 67.2% _+ 10.2% after 10 years (no 
significant difference among groups). 
Reoperations. Eighteen reoperations were per- 
formed for various reasons in the 200 patients (9%). 
Indications for reoperations included structural and 
nonstructural valve failure (10/18: 56%), progres- 
sion of dissection or aneurysm (6/18: 33%), and 
suture dehiscence resulting in development of a 
false aneurysm (2/18: 11%). Distribution of reopera- 
tions as a function of the analyzed groups is detailed 
in Table II. The proportion of redo operations for 
3 8 6 yon Segesser et al. 




Fig. 5. Actuarial probability of freedom from reoperation for patients with preserved or repaired aomc 
valves (squares) versus those with mechanical ortic valves (rhombi) versus those with biologic aortic valves 
(triangles) (_+95% errors). There is no statistically significant difference among roups. 
the main grOups was 13 of 134 (10%) in patients with 
a supracoronary graft, 5 of 66 (8%) for patients with 
a composite graft, 11 of 111 (10%) for patients with a 
preserved or repaired native aortic valve, 5 of 69 
(7%) for patients with a mechanical valve, and 2 of 
20 (10%)for patients with a biologic valve. 
Ten reoperations were performed for structural 
and nonstructural valve failure (10/200: 5%): 6 of 
111 (5%) in the group with a preserved or repaired 
native aortic valve, 3 Of 69 (4%) in the group with a 
mechanical aortic valve, and 1 of 20 (5%) in the 
group with a biologic aortic valve. Only reoperations 
for structural valve failure were considered for the 
following actuarial analyses: Probability of actuarial 
freedom from reoperation for structural valve fail- 
ure in the complete series (158/200 patients: 79%) 
was calculated as 100.0% _+ 0.0% after 30 days, 
99.3% _+ 0.7% after 1 year, 97.5% ± 1.5% after 5 
years, and 95.1% ± 2.8% after 10 years (Fig. 3). For 
early survivors with a suprac0ronary graft (102/158 
patients: 65%), actuarial freedom from reoperation 
was 100.0% ± 0.0% after 30 days, 98.9% ± 1.1% 
after 1 year, 97.4% _ 1.8% after 5 years, and 
93.6% ± 4.1% after 10 years. For early survivors 
with a composite graft (56/158 patients: 35%), free- 
dom from reoperation was 100.0% + 0.0% after 
30 days and 1 year, 97.8% ± 2.2% after 5 years, and 
97.8% _+ 2.2% after 10 years (no significant differ- 
ence among groups) (Fig. 4). 
For early survivors in whom the native aortic valve 
was Preserved or repaired (82/158 patients: 52%), 
freedom from reoperation for valve failure was 
100.0% ± 0.0% after 30 days, 98.6% ± 1.4% after 
1 year, 96.7% ± 2.3% after 5 years, and 91.2% ± 
5.8% after 10 years. For early survivors With a 
mechanical valve (57/158 patients: 36%), the corre- 
sponding figures were 100.0% ± 0.0% after 30 days 
and 1 year, 97.8% ± 2.2% after 5 years, and 
97.8% ± 2.2% after 10 years. For early survivors 
who received a biologic valve (19/158 patients: 
i2%), freedom from reoperation for valve failure 
was 100.0% + 0.0% at 30 days, 1 year, 5 years, and 
10 years of follow-up (no significant difference 
among groups) (Fig. 5). 
Other complications. Freedom from thrombo- 
embolism for all early survivors (158/200 patients: 
79%) was 98.0% ± 1.1% after 30 days, 98.0% ± 
1.1% after 1 year, 96.8% ± 1.7% after 5 years, and 
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Fig. 6. Actuarial freedom from thromboembolism forpatients with preserved or repaired native aortic 
valves (squares) versus those with mechanical ortic valves (rhombi) versus those with biologic aortic valves 
(triangles) (+95% errors). There is no statistically significant difference among roups. 
96.8% + 1.7% after 10 years. For early survivors 
with a preserved or repaired native aortic valve 
(82/158 patients: 52%), freedom from thromboem- 
bolism was 97.5% _+ 1.8% after 30 days, 1 year, 5 
years, and 10 years. For patients a with mechanical 
valve (57/158 patients: 36%), the corresponding 
figures were 98.3% +_ 1.7% after 30 days and 1 year 
and 94.7% +_ 3.9% after 5 and 10 years. No throm- 
boembolic omplications were observed in the few 
patients with biologic valves (no significant differ- 
ence among groups) (Fig. 6). No hemorrhage re- 
lated to anticoagulation was recorded in either 
group, and neither thrombotic occlusion or endo- 
carditis was documented. 
Late events. Late events including valve failure, 
reoperation, thromboembolic events, thrombotic 
valve obstruction, anticoagulant-related hemor- 
rhage, endocarditis, and others are summarized 
here. Freedom from late events for all early survi- 
vors (158/200 patients: 79%) was 93.3% _+ 2.1% 
after 1 year, 87.8% + 3.1% after 5 years, and 
83.3% _+ 4.3% after 10 years. Freedom from late 
events for patients with supracoronary aortic grafts 
(82/158 patients: 52%) was 91.6% _+ 2.9% after 
1 year, 88.3% _+ 3.6% after 5 years, and 81.3% + 
6.8% after 10 years. For patients with composite 
grafts (56/158: 35%), the respective figures were 
96.6% _+ 2.3% after 1 year and 87.5% + 5.6% after 
5 years and 10 years (no significant difference among 
groups) (Figl 7). 
Analysis as a function of the type of valve in the 
aortic position provided the following probabilities: 
In early survivors with a preserved or repaired native 
aortic valve (82/158 patients: 52%), freedom from 
late events was 89.5% _+ 3.5% after 1 year, 85.3% + 
4.5% after 5 years, and 75.5% _+ 7.6% after 10 years. 
For early survivors with a mechanical aortic valve 
(57/158 patients: 36%), freedom from late events 
was 96.6% + 2.4% after 1 year and 90.9% +__ 4.6% 
after 5 and 10 years. For early survivors with a 
biologic aortic valve (19/158 patients: 12%), the 
respective figures were 95.0% _+ 4.9% after 1 year 
and 88.5% ± 7.8% after 5 and 10 years (no signifi- 
cant difference among groups) (Fig. 8). 
Discussion 
During repair of acute type A aortic dissections, 
preservation or repair of the native aortic valve can 
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Fig. 7. Actuarial freedom from late events for patients with supracoronary grafts (squares) versus those 
with composite grafts (rhombi) (_+95% errors). There is no statistically significant difference between 
groups. 
be recommended for the majority of patients. This 
study demonstrates that throughout the follow-up 
period of more than 10 years, the performance of 
preserved or repaired native aortic valves left in situ 
was adequate. All analyzed parameters including 
freedom from structural and nonstructural valve 
failure resulting in reoperation, freedom from 
thromboembolic events, freedom from anticoagu- 
lant-related hemorrhage, and freedom from endo- 
carditis were similar for the three analyzed aortic 
valve types, namely, native repaired aortic valves, 
mechanical devices, and biologic devices (see also 
Fig. 5). Although the number of biologic valves used 
is relatively small, this group is interesting to observe 
because anticoagulation can be avoided, as in native 
repaired aortic valves. Instances of thromboembo- 
lism are analyzed in Fig. 6, which clearly shows that 
there are no differences between native and re- 
paired aortic valves versus mechanical devices ver- 
sus biologic devices. In addition, no instances of 
thrombotic occlusion or anticoagulant-related h m- 
orrhage occurred in either group. Compilation of 
late events and graphic layout in Fig. 8 demonstrates 
that the curves illustrating actuarial freedom from 
late events have overlapping error bars, which again 
preclude significant differences among the three 
types of valves analyzed. 
These findings confirm previous work by the 
Stanford group, l° who reported reoperations for 
valve failure in 2 of 46 patients (4%) with resuspen- 
sion and in 4 of 75 patients (5%) with previous valve 
replacement (no significant difference). Freedom 
from aortic valve replacement at 5 and 10 years in 
their series was 100% and 80% _+ 13% for resus- 
pension versus 98% + 2% and 73% + 13% for 
initial aortic valve replacement. We agree with the 
authors' conclusion stating satisfactory durability of 
aortic valve resuspension, coupled with the absence 
of potential complications related to the prosthetic 
valve and need for indefinite anticoagulation. 
With regard to reoperation, in the series of 32 
patients reported on by Bachet and associates, 14
only four of 42 redo operations were done for valve 
disease (10%). In their series, the main reason for 
reoperation was evolution of aneurysmal disease, an 
observation that confirms again that function of 
repaired native aortic valves is generally good. Pres- 
ervation of the aortic valve in acute aortic dissection 
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Fig. 8. Actuarial freedom from late events for patients with preserved or repaired native aortic valves 
(squares) versus those with mechanical ortic valves (rhombi) versus those with biologic aortic valves 
(triangles) (+_95% errors). There is no statistically significant difference among groups. 
was also analyzed by Mazzucotelli and colleagues. 15
They found actuarial freedom from aortic valve 
reoperation i 83% ± 6% at 5 years and 79% + 7% 
at 10 years. In their series, echocardiographic 
follow-up studies showed no or mild aortic insuffi- 
ciency in 22 of 41 patients (54%) and moderate 
aortic insufficiency with satisfactory left ventricular 
function in 12 of 41 patients (29%). Overall, aortic 
valve replacement was necessary in 8 patients of 
their series, and they are included in the actuarial 
reoperation rates mentioned. Actuarial survival in 
their series was 63% ± 6% at 5 years, 55% ± 7% at 
10 years, and 39% ± 9% at 15 years for patients with 
a repaired aortic valve. For hospital survivors, the 
respective figures were 83% ± 6% after 5 years and 
79% ± 9% after 10 years. These figures are similar 
to those of early survivors who underwent supra- 
coronary grafting in the series presented here. 
The results of our series and those cited from the 
literature, as recently compiled by Grunkemeier and 
Bodnar, ~6 show that native aortic valves preserved 
or repaired during operations on the ascending 
aorta for cure of type A dissection perform at least 
as well as the various bioprostheses u ed for simple 
aortic valve replacement. 
Regardless of the aortic valve repair or replace- 
ment technique selected, 17 evaluation of aortic valve 
competence, left ventricular function, and aortic 
wall expansion are warranted at regular intervals 
during long-term follow-up of all patients with a 
history of aortic dissection. The known risk factors 
for the primary event, namely, systemic hyperten- 
sion, the Marfan syndrome, congenitally bicuspid or 
unicommissural valves, and to a lesser degree aortic 
medial degeneration and rupture of ulcerocalcific 
atheromas, 18 may also play a role in secondary 
events at the same site or at another aortic site 
distant from the primary lesion. ~9 
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Discussion 
Mr. Stephen Westaby (Oxford, England). The study 
period covers a time during which surgical techniques in 
aortic dissection changed considerably. I would like to 
concentrate my remarks specifically on the long-term 
integrity of valve repair, because the surgical methods 
have changed from suspension with Teflon pledgets to the 
use of glue in Europe. 
I have one criticism of the study design. The authors did 
not differentiate the degree of aortic regurgitation for 
their individual patients but collectively assessed the out- 
come for all patients who did not receive a prosthetic 
valve. 
In practice, only 40% to 60% of patients with acute type 
A dissection have moderate or severe aortic regurgitation. 
A large number do not have significant aortic regurgita- 
tion. This begs the question whether it is valid to 
determine the efficacy of valve repair without detailed 
preoperative and postoperative assessment of aortic re- 
gurgitation in individual patients. 
I would like to bring to your notice a series of 170 
patients with acute type A dissection. The Stanford and 
Duke groups believed that a procedure to repair or 
replace the aortic valve was necessary in only 75 of them. 
Their judgment was that the aortic valve was sound in the 
majority of their patients. In your study the patients with 
mild or absent aortic regurgitation are included in the 
overall numbers of patients having valve repair. 
In Europe the availability gelatin-resorcin-formol and 
fibrin glues has changed the conduct of surgery for type A 
dissection very considerably. I suspect hat in Zurich glue 
was used predominantly in the latter half of the investi- 
gation. Comparing 100 cases from Oxford in the past 8 
years (predominantly in the glue era), we were able to 
repair the aortic valve in 84% of patients with acute type 
A dissection. With an increasing number of valve repairs 
and fewer replacements, the hospital mortality in Oxford 
has dropped progressively, and we have also found that 
the valve repair is sound over the long term. 
Dr. von Segesser, what has been the influence of glue 
on the rate of repair and the long-term integrity of the 
aortic sinuses in the patients treated for aortic dissection? 
Dr. yon Segesser. We have tried to analyze the results of 
this series as a function of aortic incompetence or regur- 
gitation. Unfortunately, it is difficult to assess the regur- 
gitation fraction in patients who underwent only com- 
puted tomographic scan before the operation. On the 
other hand, nowadays with transesophageal chocardiog- 
raphy we detect some degree of regurgitation i almost all 
patients. Thus because of the long time period analyzed, 
from 1979 to 1992, and the substantially modified tech- 
niques of evaluation, we could not reliably assess the 
degree of regurgitation. That is why we distinguished only 
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the type of tissue left in place finally--native, biologic, or 
mechanical. 
The importance of glue has been increasing in the 
surgical treatment of patients with this disease. Initially, of 
course, we used Teflon felt strips and pledgets to repair 
these lesions. Now, we do not merely repair the valve. 
Rather, in a substantial number of cases, the repair can be 
effected entirely with the use of glue, and no graft is used. 
I could not continue with this study because after 1992 a 
substantial number of the patients had no graft inserted. 
Dr. Hans G. Borst (Hannover, Germany). This is one of 
the largest and best studied groups of patients with acute 
type A dissection worldwide. The authors' reoperation 
rate of only 5% at 10 years after aortic valve reconstruc- 
tion in acute dissection is a remarkable result. Dr. yon 
Segesser's data confirm our view that the great majority of 
aortic valves can be preserved in acute proximal dissec- 
tion, thereby avoiding valve replacement. The risk of 
anticoagulant-related bleeding in dissection is much 
greater than in the normal population, of course, because 
aneurysmal disease tends to develop elsewhere in these 
patients. 
Postoperative failures of these valve reconstructions 
(not supracommissural grafting) do occur and, in our 
experience, fall into one of two categories: (1) breakdown 
of the surgical repair and (2) failure of the physician to 
properly assess the underlying root disease. Thus, in our 
experience with 80 patients urviving valve resuspension 
in the acute stage during the past 15 years, seven subse- 
quently required reoperation for aortic regurgitation. In
three the repair had disrupted, and in another two root 
ectasia had developed in the midterm. In one case both 
mechanisms were present, and an additional patient had a 
leaflet defect that probably had been overlooked at the 
primary operation. 
As our experience with acute dissection has increased, 
we have been able to avoid disruption of the original 
repair entirely by using advanced techniques of commis- 
sural resuspension. In our hands, this now includes rou- 
tine gelatin-resorcin-formol gluing of the aortic wall lay- 
ers. Regardless of this aspect, my message here is that the 
aortic root must be carefully examined for even discrete 
ectasia. In case of doubt and in all patients with known or 
suspected connective tissue disorders, the root should be 
replaced. The newer alternative to replacement, of course, 
is Dr. Tirone David's root remodeling procedure, which 
we also use in acute dissection in patients who are in 
otherwise stable condition. 
Dr. von Segesser, which types of valves are you pres- 
ently excluding from reconstruction? 
Dr. yon Segesser. We repair valves that were healthy 
before dissection and we use composite graft repair in 
patients with enlarged roots. Of course, a patient with 
full-blown Marfan's syndrome would have a composite 
graft repair in this type of setting, However, there are a 
number of patients in whom it is not clear if Maffan's 
syndrome is really present. In these patients, if the aortic 
root has an acceptable configuration and diameter, we 
would attempt repair initially. 
Dr. Aubrey C. Galloway (New York, N.Y.). We have a 
similar series of more than 100 patients having repair of 
type A dissection since 1985. In that group we have been 
able to reconstruct more than 90% of the valves in 
patients with significant aortic insutficiency. We think it is 
very important to reconstruct the entire sinotubular junc- 
tion, much as one does for the distal end of a freehand 
homograft. If that is done in a 360-degree fashion, most 
valves are correctable. The noncoronary sinus can be 
obliterated by taking a tongue of the graft down close to 
the anulus. Only a small group of our patients, less than 
5%, required aortic root replacement. I noticed in your 
series that 33% required this procedure. What are the 
specific criteria for replacing the root? Is it true annu- 
loaortic ectasia with displacement of the coronaries or are 
you instead replacing some roots in which only the 
noncoronary sinus is distorted? If so, we think most of 
those can be repaired. 
Finally, I have a last small but important criticism. I
think it is impressive that actuarial data suggest a 5% 
reoperation rate at 10 years, but what was the mean 
follow-up interval and how many patients do you actually 
have in the repair group at 5 years and at 10 years? This 
information obviously would be important for us to know 
to weigh your data appropriately. 
Dr. von Segesser. The original group of 150 surviving 
patients was followed up for 172 months maximum. Mean 
follow-up was 50 months. At 10 years of follow-up there 
were 20 patients in the overall group. Corresponding 
figures are given in the article for every time segment in 
every subgroup. After 7 years of follow-up there are fewer 
than 10 patients in some groups. Therefore, the reliability 
of the actuarial analysis and comparisons of these groups 
is no longer very good, and not too much attention should 
be paid to these differences. 
With regard to root replacements, we consider it nec- 
essary for significant enlargement of the anulus or for 
significant enlargement of the sinus portion of the ascend- 
ing aorta. In all of the other cases the root can be repaired. 
With the gluing technique the ascending aorta can be 
reconstructed so that there is no visible difference be- 
tween the normal aorta and the glued aorta after this 
procedure. 
